Integrative analysis of copy number and gene expression in breast cancer using formalin-fixed paraffin-embedded core biopsy tissue: a feasibility study

Background: An absence of reliable molecular markers has hampered individualised breast cancer treatments, and a major limitation for translational research is the lack of fresh tissue. There are, however, abundant banks of formalinfixed paraffin-embedded (FFPE) tissue. This study evaluated two plat...

Full description

Bibliographic Details
Main Authors: Iddawela, Mahesh, Rueda, Oscar, Eremin, Jenny, Eremin, Oleg, Cowley, Jed, Earl, Helena M., Caldas, Carlos
Format: Article
Published: BioMed Central 2017
Subjects:
Online Access:https://eprints.nottingham.ac.uk/51338/
_version_ 1848798473311223808
author Iddawela, Mahesh
Rueda, Oscar
Eremin, Jenny
Eremin, Oleg
Cowley, Jed
Earl, Helena M.
Caldas, Carlos
author_facet Iddawela, Mahesh
Rueda, Oscar
Eremin, Jenny
Eremin, Oleg
Cowley, Jed
Earl, Helena M.
Caldas, Carlos
author_sort Iddawela, Mahesh
building Nottingham Research Data Repository
collection Online Access
description Background: An absence of reliable molecular markers has hampered individualised breast cancer treatments, and a major limitation for translational research is the lack of fresh tissue. There are, however, abundant banks of formalinfixed paraffin-embedded (FFPE) tissue. This study evaluated two platforms available for the analysis of DNA copy number and gene expression using FFPE samples. Methods: The cDNA-mediated annealing, selection, extension, and ligation assay (DASL™) has been developed for gene expression analysis and the Molecular Inversion Probes assay (Oncoscan™), were used for copy number analysis using FFPE tissues. Gene expression and copy number were evaluated in core-biopsy samples from patients with breast cancer undergoing neoadjuvant chemotherapy (NAC). Results: Forty-three core-biopsies were evaluated and characteristic copy number changes in breast cancers, gains in 1q, 8q, 11q, 17q and 20q and losses in 6q, 8p, 13q and 16q, were confirmed. Regions that frequently exhibited gains in tumours showing a pathological complete response (pCR) to NAC were 1q (55%), 8q (40%) and 17q (40%), whereas 11q11 (37%) gain was the most frequent change in non-pCR tumours. Gains associated with poor survival were 11q13 (62%), 8q24 (54%) and 20q (47%). Gene expression assessed by DASL correlated with immunohistochemistry (IHC) analysis for oestrogen receptor (ER) [area under the curve (AUC) = 0.95], progesterone receptor (PR)(AUC = 0.90) and human epidermal growth factor type-2 receptor (HER-2) (AUC = 0.96). Differential expression analysis between ER+ and ER– cancers identified over-expression of TTF1, LAF-4 and C-MYB (p ≤ 0.05), and between pCR vs non-pCRs, over-expression of CXCL9, AREG, B-MYB and under-expression of ABCG2. Conclusion: This study was an integrative analysis of copy number and gene expression using FFPE core biopsies and showed that molecular marker data from FFPE tissues were consistent with those in previous studies using fresh-frozen samples. FFPE tissue can provide reliable information and will be a useful tool in molecular marker studies.
first_indexed 2025-11-14T20:20:20Z
format Article
id nottingham-51338
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T20:20:20Z
publishDate 2017
publisher BioMed Central
recordtype eprints
repository_type Digital Repository
spelling nottingham-513382020-05-04T18:54:55Z https://eprints.nottingham.ac.uk/51338/ Integrative analysis of copy number and gene expression in breast cancer using formalin-fixed paraffin-embedded core biopsy tissue: a feasibility study Iddawela, Mahesh Rueda, Oscar Eremin, Jenny Eremin, Oleg Cowley, Jed Earl, Helena M. Caldas, Carlos Background: An absence of reliable molecular markers has hampered individualised breast cancer treatments, and a major limitation for translational research is the lack of fresh tissue. There are, however, abundant banks of formalinfixed paraffin-embedded (FFPE) tissue. This study evaluated two platforms available for the analysis of DNA copy number and gene expression using FFPE samples. Methods: The cDNA-mediated annealing, selection, extension, and ligation assay (DASL™) has been developed for gene expression analysis and the Molecular Inversion Probes assay (Oncoscan™), were used for copy number analysis using FFPE tissues. Gene expression and copy number were evaluated in core-biopsy samples from patients with breast cancer undergoing neoadjuvant chemotherapy (NAC). Results: Forty-three core-biopsies were evaluated and characteristic copy number changes in breast cancers, gains in 1q, 8q, 11q, 17q and 20q and losses in 6q, 8p, 13q and 16q, were confirmed. Regions that frequently exhibited gains in tumours showing a pathological complete response (pCR) to NAC were 1q (55%), 8q (40%) and 17q (40%), whereas 11q11 (37%) gain was the most frequent change in non-pCR tumours. Gains associated with poor survival were 11q13 (62%), 8q24 (54%) and 20q (47%). Gene expression assessed by DASL correlated with immunohistochemistry (IHC) analysis for oestrogen receptor (ER) [area under the curve (AUC) = 0.95], progesterone receptor (PR)(AUC = 0.90) and human epidermal growth factor type-2 receptor (HER-2) (AUC = 0.96). Differential expression analysis between ER+ and ER– cancers identified over-expression of TTF1, LAF-4 and C-MYB (p ≤ 0.05), and between pCR vs non-pCRs, over-expression of CXCL9, AREG, B-MYB and under-expression of ABCG2. Conclusion: This study was an integrative analysis of copy number and gene expression using FFPE core biopsies and showed that molecular marker data from FFPE tissues were consistent with those in previous studies using fresh-frozen samples. FFPE tissue can provide reliable information and will be a useful tool in molecular marker studies. BioMed Central 2017-07-11 Article PeerReviewed Iddawela, Mahesh, Rueda, Oscar, Eremin, Jenny, Eremin, Oleg, Cowley, Jed, Earl, Helena M. and Caldas, Carlos (2017) Integrative analysis of copy number and gene expression in breast cancer using formalin-fixed paraffin-embedded core biopsy tissue: a feasibility study. BMC Genomics, 18 (1). p. 526. ISSN 1471-2164 Gene Expression Copy Number FFPE Genomics Breast Cancer DASL Molecular Inversion Probes Assay Oncoscan Array Molecular Markers https://doi.org/10.1186/s12864-017-3867-3 doi:10.1186/s12864-017-3867-3 doi:10.1186/s12864-017-3867-3
spellingShingle Gene Expression
Copy Number
FFPE
Genomics
Breast Cancer
DASL
Molecular Inversion Probes Assay
Oncoscan Array
Molecular Markers
Iddawela, Mahesh
Rueda, Oscar
Eremin, Jenny
Eremin, Oleg
Cowley, Jed
Earl, Helena M.
Caldas, Carlos
Integrative analysis of copy number and gene expression in breast cancer using formalin-fixed paraffin-embedded core biopsy tissue: a feasibility study
title Integrative analysis of copy number and gene expression in breast cancer using formalin-fixed paraffin-embedded core biopsy tissue: a feasibility study
title_full Integrative analysis of copy number and gene expression in breast cancer using formalin-fixed paraffin-embedded core biopsy tissue: a feasibility study
title_fullStr Integrative analysis of copy number and gene expression in breast cancer using formalin-fixed paraffin-embedded core biopsy tissue: a feasibility study
title_full_unstemmed Integrative analysis of copy number and gene expression in breast cancer using formalin-fixed paraffin-embedded core biopsy tissue: a feasibility study
title_short Integrative analysis of copy number and gene expression in breast cancer using formalin-fixed paraffin-embedded core biopsy tissue: a feasibility study
title_sort integrative analysis of copy number and gene expression in breast cancer using formalin-fixed paraffin-embedded core biopsy tissue: a feasibility study
topic Gene Expression
Copy Number
FFPE
Genomics
Breast Cancer
DASL
Molecular Inversion Probes Assay
Oncoscan Array
Molecular Markers
url https://eprints.nottingham.ac.uk/51338/
https://eprints.nottingham.ac.uk/51338/
https://eprints.nottingham.ac.uk/51338/